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Abstract Purpose: The aim of
this study is to assess the incidence of
sublingual microcirculatory flow
alterations, according to a predefined
arbitrary cutoff value, in patients with
‘‘clinical signs of impaired organ
perfusion’’. Secondary endpoints
were the changes in microvascular
flow index (MFI), ‘‘clinical signs of
impaired organ perfusion’’, and stroke
volume (SV) after fluid administra-
tion, and the differences between
groups. Methods: Prospective, sin-
gle-center, observational study in a
22-bed mixed intensive care unit
(ICU). Patients C18 years with inva-
sive hemodynamic monitoring and
‘‘clinical signs of impaired organ
perfusion’’ as the principal reason for
fluid administration were included.
Before and after fluid challenge, sys-
temic hemodynamics and direct
in vivo observation of the sublingual
microcirculation with sidestream
dark-field imaging were obtained.
Microvascular flow index (MFI)\2.6
was predefined as abnormal.
Results: N = 50. At baseline,
MFI \2.6 was present in 66 % of
the patients. In these patients, MFI
increased from 2.3 (2–2.5) at baseline
to 2.5 (2.1–2.8) after fluid challenge
(p = 0.003). This was accompanied
by a reduction in the number of
‘‘clinical signs of impaired organ
perfusion’’ from 2 (1–2) to 1 (0–2)
(p \ 0.001). However, in patients
with MFI [2.6 at baseline, MFI and
clinical signs changed insignificantly
[2.8 (2.8–2.9) versus 2.8 (2.7–3),
p = 0.45, respectively, 1 (1–2) versus
1 (1–2), p \ 0.32]. These changes
were not restricted to patients with a
rise in SV C10 %.
Conclusions: These data add to the
understanding that noninvasive
assessment of microvascular blood
flow may help to identify patients
eligible for fluid therapy, and to
evaluate its effect.
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Introduction
Fluid therapy is a cornerstone of the treatment of hemo-
dynamically unstable critically ill patients [1]. Principal
reasons for fluid therapy are correction of hypovolemia
and improvement of tissue perfusion. Fluid challenge
techniques have replaced static filling pressures as
predictors of preload dependency, being used in clinical
practice to evaluate the patient’s response to fluids and to
avoid pulmonary edema [2]. The generally accepted
concept of ‘‘fluid responsiveness’’ is defined at the level
of the heart, according to the Frank–Starling principle. A
practical limitation of such an approach is that nonre-
sponders also receive fluids, since the test is evaluated
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after fluid administration. Passive leg raising and
functional hemodynamic variables, derived from the
assessment of the dynamic interactions between circulation
and ventilation, may help to predict ‘‘fluid responsiveness’’,
although being hampered by many practical limitations [3,
4]. However, such a macrohemodynamic perspective does
not address the fundamental issue of ‘‘adequate’’ organ
perfusion. How can one define and select patients with
‘‘inadequate’’ organ perfusion other than by clinical or
biochemical signs of organ dysfunction? And does organ
perfusion indeed improve in case of macrohemodynamic
‘‘fluid responsiveness’’?
New microcirculatory imaging techniques, such as
orthogonal polarization spectral (OPS) imaging [5] and its
technical successor sidestream dark-field (SDF) imaging
[6], have allowed direct observation of microcirculation at
the bedside. Conceptually such techniques enable us to
arbitrate tissue perfusion directly. In animal models of
hemorrhagic shock blood loss and fluid therapy was
indeed reflected in microcirculatory blood flow [7, 8].
Pottecher et al. [9] showed that both passive leg raising
and volume expansion improved sublingual microcircu-
latory perfusion during the first 24 h of ICU stay in
preload-responsive severe sepsis and septic shock
patients. Others observed that fluid challenge improved
microvascular perfusion in the early but not late phase of
severe sepsis and suggested this effect to be independent
from systemic hemodynamics and type of fluids [10].
The aim of this study is to address the following
questions: (1) If the clinician is confronted with presumed
‘‘clinical signs of impaired organ perfusion,’’ than what is
the actual incidence of abnormal organ perfusion when
observed with direct in vivo microscopy? (2) How do
patients with abnormal organ perfusion at baseline
respond to fluid administration in terms of organ perfu-
sion (in vivo microscopy) and organ function (clinical
signs)? (3) Is this response different in comparison with
patients with normal organ perfusion at baseline? (4) Is an
improvement in organ perfusion restricted to patients with
a rise in stroke volume (SV) C10 % after fluid adminis-
tration? We anticipated that red blood cell velocity, rather
than capillary density, would respond directly to fluid
administration; therefore we chose the microvascular flow




The study was performed between January and March
2011 in a closed-format 22-bed mixed ICU in a tertiary
teaching hospital. It was designed as a prospective, single-
center, observational clinical trial and is registered with
ClinicalTrials.gov with number NCT01369524. All ICU
patients of at least 18 years of age with an invasive car-
diac output device in situ were eligible for assessment
within the first 6 h of ICU admittance. The principal
reason for inclusion was the clinical need for fluid ther-
apy, according to one or more predefined signs of
impaired organ perfusion: tachycardia [100 beats/min,
after exclusion of pain/discomfort; impaired skin perfu-
sion (subjective assessment); oliguria (\0.5 ml/kg/h);
mean arterial blood pressure (MAP) \65 mmHg in
combination with central/mixed venous oxygen saturation
[S(c)vO2] \65 %; hyperlactatemia ([2.2 mmol/l). Rea-
son for exclusion was recent oropharyngeal surgery. A
local ethical and scientific committee approved the study
protocol, and written informed consent was obtained from
the patients or their surrogate decision-makers, consistent
with applicable laws.
Protocol
Systemic hemodynamic assessment was achieved through
continuous invasive monitoring of arterial blood pressure
and right heart catheterization with continuous cardiac
output measurements (Vigilance; Edwards Lifesciences,
Saint-Prex, Switzerland). Alternatively, a designated
femoral artery thermodilution catheter was used in com-
bination with a central venous line above the diaphragm
(PiCCO; Pulsion Medical Systems, Munich, Germany).
Pulse contour analysis of arterial waveforms was per-
formed after calibration with transpulmonary bolus
thermodilution. The general aim of the hemodynamic
treatment was cessation of the previously defined signs of
impaired organ perfusion. In case these endpoints were
not met, the first step was to initiate a fluid challenge. This
was performed by infusion of 500 ml crystalloid solu-
tion (NaCl 0.9 %) or balanced colloid solution (6 %
hydroxyethyl starch 130/0.4 in a sodium acetate-based
isotonic solution, Volulyte; Fresenius-Kabi, Bad-Hom-
burg, Germany) in 30 min; the choice of fluid type was
made by the attending physician.
Imaging and analysis
Sidestream dark-field imaging is a stroboscopic light-
emitting diode ring-based imaging modality that is
incorporated in a handheld device [6]. The device illu-
minates an area of interest for clinical observation of the
microcirculation. If a wavelength within the hemoglobin
absorption spectrum (e.g., 530 nm) is chosen, red blood
cells will appear dark. Semiquantitative analysis was
performed as described in detail elsewhere [11]. In short,
a minimum of three steady images of at least 10 s in
duration were obtained from the sublingual region by a
research investigator other than the attending physician.
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After gentle removal of saliva by an isotonic-saline-
drenched gauze and avoiding pressure artifacts, images
were acquired and stored on a digital videotape (SONY
Video Walkman GV-D 1000E; Sony, Tokyo, Japan).
Subsequently, the images were captured in 5–10 s rep-
resentative AVI format video clips (SonyDVgate; Sony,
Tokyo, Japan). Video clips were blindly analyzed offline
by an investigator who had no involvement in the data
collection. The images were presented in random order so
as to prevent interimage coupling. SDF images were
obtained from three different locations within the sub-
lingual region, and each image was divided into four
equal quadrants. Quantification of flow (no flow: 0;
intermittent flow: 1; sluggish flow: 2; continuous flow: 3)
was scored per quadrant, for each vessel diameter
cohort (small: 10–20 lm; medium: 21–50 lm; large:
51–100 lm). The MFI was calculated as the sum of each
quadrant score divided by the number of quadrants in
which the vessel type was visible. The final MFI was
averaged over a maximum of 12 quadrants (three regions,
four quadrants per region) derived from the overall flow
impressions of all vessels with a particular range of
diameter in a given quadrant. The heterogeneity index
was calculated, following the method of Trzeciak and
colleagues [12], as the difference between the highest and
lowest MFI, divided by the mean MFI of all sublingual
sites at a single time point. Calculation of total (small)
vessel density (TVD) was performed with the AVA 3.0
software package (MicroVision Medical, Amsterdam,
The Netherlands), as described and validated recently
[13], using a cutoff diameter for small vessels of\20 lm.
After stabilization of the images using the AVA 3.0
software, we defined the perfused (small) vessel density
(PVD) and the proportion of perfused (small) vessels
(PPV) in terms of the number and percentage of crossings
with perfused (small) vessels per total length of three
equidistant horizontal and three equidistant vertical lines.
This method has been described elsewhere by de Backer
et al. and is in accordance with reports of a round-table
conference [14].
Data collection
The following data were recorded at baseline: general
characteristics, routine laboratory results, ventilator set-
tings, and severity of illness according to Acute
Physiology and Chronic Health Evaluation (APACHE) IV
and Sequential Organ Failure Assessment (SOFA) scores,
calculated over the first 24 h following ICU admission
[15, 16]. Systemic hemodynamic variables, SDF images,
arterial lactate concentrations, and blood gases were
recorded at baseline and directly after the fluid challenge
(30 min after baseline). At baseline, patient groups were
defined according to MFI\2.6 (‘‘low MFI’’) or MFI C2.6
(‘‘high MFI’’). The primary endpoint was the percentage
of patients with MFI\2.6 at baseline. The cutoff for MFI
was set as 2.6 prior to the start of the study (Clinical-
Trials.gov, NTC 00493415), since this reflects the
minimum reported lower threshold of the 95 % confi-
dence interval in healthy or nonseptic ICU controls [12,
17–20]. Secondary endpoints were the changes in MFI,
‘‘clinical signs of impaired organ perfusion,’’ and SV after
fluid administration, and the differences in response
between groups.
Statistical analysis
Baseline data for a power calculation were not available.
Alternatively, a study period of 3 months was chosen to
obtain a sample size of 30–50 patients, in analogy to
previous publications [7, 9, 10]. The Statistical Package
for Social Sciences (SPSS 15.1 for Windows, Chicago,
IL, USA) was used for statistical analyses. For continuous
variables, all data are presented as median and inter-
quartile range (IQR). Comparison between groups of non-
normally distributed microvascular parameters (MFI,
TVD, PPV, PVD) was performed with a Mann–Whitney
U test. Comparison against baseline of systemic and
microcirculatory hemodynamic parameters after inter-
vention was performed with a paired t test, or with a
Wilcoxon signed-rank test in case of normally distributed
variables. For dichotomous variables a Fisher’s exact test
was performed. A two-sided p value of \0.05 was con-
sidered statistically significant.
Results
Out of 57 patients who were eligible for the study, 50
patients were included; in seven cases informed consent
could not be obtained. Baseline characteristics are pre-
sented in Table 1. Sixty-six percent (33/50) of the patients
had MFI \2.6 at baseline. The median number of ‘‘clin-
ical signs of impaired organ perfusion’’ was 1 (1–2).
Post hoc, a receiver operating characteristic (ROC) curve
confirmed a MFI of 2.6 as the optimal cutoff value with
respect to the clinical response to fluid administration.
Low MFI group (MFI\2.6 at baseline, n = 33): After
fluid challenge central venous pressure (CVP), SV index
(SVi), and S(c)VO2 rose significantly, together with a
reduction in heart rate (Table 2). Median MFI of small
vessels, as a marker of capillary blood flow, increased
significantly from 2.3 (2–2.5) at baseline to 2.5 (2.1–2.8)
after fluid challenge (p = 0.003) (Table 3; Fig. 1). In
conjunction with the rise in MFI the median number of
‘‘clinical signs of impaired organ perfusion’’ reduced
from 2 (1–2) to 1 (0–2) (p \ 0.001) (Fig. 2). The number
of patients with a reduction in number of ‘‘clinical signs
of impaired organ perfusion’’ after fluid challenge was 15
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(45 %). TVD of small vessels, as a marker of capillary
density, did not change significantly from 30 (27–34)
mm/mm2 at baseline to 31 (26–36) mm/mm2 (p = 0.48).
High MFI group (MFI C2.6 at baseline, n = 17):
After fluid challenge SVi rose significantly, together with
a reduction in heart rate (Table 2). However, median MFI
of small vessels remained unaltered: 2.8 (2.8–2.9) at
baseline versus 2.8 (2.7–3) (p = 0.45) (Table 3; Fig. 1).
Also, the number of ‘‘clinical signs of impaired organ
perfusion’’ did not change significantly, from 1 (1–2) at
baseline versus 1 (1–2) after fluid challenge (p \ 0.32)
(Fig. 2). The number of patient with a reduction in
number of ‘‘clinical signs of impaired organ perfusion’’
after fluid challenge was 3 (18 %). In comparison with the
low MFI group this reduction was significantly lower (45
vs. 18 %, p = 0.05). TVD of small vessels did not change
significantly: from 27 (25–32) mm/mm2 at baseline, to 28
(23–32) mm/mm2 (p = 0.72).
Responders versus nonresponders (DSVi C10 % vs.
DSVi \10 %): In 68 % of all patients SVi increased
C10 % after fluid challenge (Table 2). There was no
difference in the number of responders between the low
MFI and high MFI groups: 23/33 (70 %) versus 11/17
(65 %) (p = 0.78). In the responders (N = 34), MFI of
small vessels rose significantly from 2.5 (2.3–2.8) at
baseline to 2.7 (2.4–2.8) after fluid administration








Men, n (%) 24 (48) 17 (50) 7 (41) 0.49
Age, years 68 (61–76) 68 (62–76) 64 (55–74) 0.32
APACHE IV 71 (53–117) 68 (53–125) 72 (51–95) 0.48
SOFA 8 (5–11) 8 (5–11) 8 (4–10) 0.36
Reason for ICU admittance, n (%)
Cardiac surgery 22 (44) 12 (37) 10 (59)
Sepsis 12 (24) 10 (30) 2 (12)
CPR 10 (20) 6 (18) 4 (23)
Other 6 (12) 5 (15) 1 (6)
Mean arterial pressure, mmHg 66 (59–75) 66 (58–74) 64 (59–79) 0.59
Heart rate, beats/min 91 (90–106) 91 (88–109) 94 (90–104) 0.50
Central venous pressure, mmHg 9 (7–12) 9 (8–13) 8 (6–11) 0.19
Cardiac index, l/min m2 2.3 (1.8–3.3) 1.9 (1.7–3.3) 2.6 (1.9–3.6) 0.22
S(c)vO2, % 69 (62–73) 69 (62–73) 67 (60–73) 0.93
Dopamine dose, n, lg/kg min 9, 5.6 (2.5–10) 5, 8.4 (2.8–12.1) 4, 4.2 (2.1–9.7) 0.33
Norepinephrine dose,
n, lg/kg min
31, 0.10 (0.06–0.19) 22, 0.09 (0.04–0.14) 9, 0.19 (0.08–0.29) 0.12
Ventilator, use of, n (%) 49 (98) 33 (100) 16 (94) 1.00
PEEP, cmH2O 10 (10–12) 10 (10–13) 10 (9–12) 0.11
Lactate, baseline, mmol/l 2.2 (1.6–4.2) 2.8 (1.7–4.2) 1.7 (1.4–4.7) 0.43
pH 7.35 (7.28–7.42) 7.35 (7.29–7.41) 7.27 (7.27–7.44) 0.61
Hematocrit, % 31 (27–36) 31 (27–36) 31 (29–41) 0.50
APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, S(c)vO2
mixed/central venous oxygen saturation, PEEP positive end-expiratory pressure, low MFI microvascular flow index
\2.6, high MFI microvascular flow index C2.6. All data are presented as median (IQR) or as number (%)
Table 2 Systemic hemodynamic variables in response to fluid challenge
Variable All (n = 50) Low MFI (n = 33) High MFI (n = 17)
Baseline FC Baseline FC Baseline FC
MAP, mmHg 66 (59–75) 68 (61–79) 66 (58–74) 68 (59–79) 64 (59–79) 68 (66–85)
HR, beats/min 91 (90–106) 90 (86–100) 91 (88–109) 90 (84–105) 94 (90–104) 90 (89-100)
CVP, mmHg 9 (7–12) 11 (9–14) 9 (8–13) 11 (9–14) 8 (6–11) 10 (6–13)
SVi, ml/m
2 25 (19–32) 29 (23–38) 22 (19–29) 26 (23–31) 28 (21–29) 31 (25–34)
DSVi [10 %, n (%) 34 (68) 23 (70) 11 (65)
S(c)vO2 69 (62–73) 72 (65–78)
 69 (62–73) 72 (63-79) 67 (60–73) 71 (66–79)
Lactate, mmol/l 2.2 (1.6–4.2) 2.2 (1.4–3.9) 2.8 (1.7–4.2) 2.7 (1.7–3.9) 1.7 (1.4–4.7) 1.5 (1.2–4.2)
MAP mean arterial pressure, HR heart rate, CVP central venous pressure, SVi stroke volume index, S(c)vO2 mixed/central venous oxygen
saturation, low MFImicrovascular flow index \2.6, high MFI microvascular flow index C2.6, FC fluid challenge. All data presented as
median (IQR)
 p B 0.005,  p \ 0.05, difference in comparison with baseline
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(p = 0.02). The median number of ‘‘clinical signs of
impaired organ perfusion’’ reduced from 1.5 (1–2) to 1
(1–2) (p = 0.01). In the nonresponders (N = 16), MFI of
small vessels also rose from 2.5 (2.2–2.9) to 2.7 (2.4–2.9),
but this was insignificant (p = 0.09). The median number
of ‘‘clinical signs of impaired organ perfusion’’ reduced
from 2 (1–3) to 1.5 (1–2) (p = 0.01).
Discussion
In the present study, sublingual microvascular flow
alterations, defined as MFI \2.6, were present in two-
thirds of mixed ICU patients with presumed ‘‘clinical
signs of impaired organ perfusion.’’ Post hoc ROC anal-
ysis confirmed MFI\2.6 as the optimal cutoff value. This
indicates a rather low specificity of widely used clinical
criteria that intensive care doctors assume to be indicators
of impaired organ perfusion. In the low MFI group, fluid
administration was accompanied by significant attenua-
tion of impaired microvascular blood flow and reduction
of ‘‘clinical signs of impaired organ perfusion.’’ However,
in the high MFI group, fluid administration was associated
with neither a change in microvascular blood flow nor
mitigation of these clinical signs, suggesting alternative
causes for such symptoms in these patients. Assessment
of microcirculatory flow abnormalities, prior to fluid
therapy, may therefore be helpful to increase the pre-test
likelihood of such intervention. The data from this study
Table 3 Microcirculatory variables in response to fluid challenge
Variable All (n = 50) Low MFI (n = 33) High MFI (n = 17)
Baseline FC Baseline FC Baseline FC
MFI s 2.5 (2.3–2.8) 2.7 (2.4–2.8) 2.3 (2.0–2.5) 2.5 (2.1–2.8) 2.8 (2.8–2.9) 2.8 (2.7–3)
MFI l 3 (2.9–3) 3 (3–3) 3 (2.9–3) 3 (3–3) 3 (2.9–3) 3 (3–3)
Het MFI 0.3 (0.1–0.3) 0.2 (0.1–0.3) 0.3 (0.2–0.5) 0.3 (0.1–0.4) 0.2 (0.1–0.2) 0.2 (0.1–0.3)
PPV s (%) 90 (86–93) 91 (89–95) 88 (84–91) 91 (84–94) 94 (92–95) 94 (91–96)
TVD s, mm/mm2 29 (27–34) 31 (26–34) 30 (27–34) 31 (26–36) 27 (25–32) 28 (23–32)
PVD s, 1/mm 14 (12–17) 15 (13–18) 14 (12–17) 16 (13–18) 15 (14–16) 15 (12–17)
MFI s microvascular flow index small vessels (\20 lm), MFI l
microvascular flow index large vessels (C20 lm), Het MFI coef-
ficient of MFI s variation, PPV s percentage of perfused small
vessels, TVD s total vessel density small vessels, PVD s perfused
vessel density small vessels, low MFI microvascular flow index
\2.6, high MFI microvascular flow index C2.6, FC fluid challenge.
All data presented as median (IQR).  p B 0.005 in comparison
with baseline
Fig. 1 Boxplots of the microvascular flow index (MFI) in response
to fluid administration in patients with MFI \2.6 (low MFI) and
C2.6 (high MFI) at baseline. *p \ 0.005
Fig. 2 Change in number of ‘‘clinical signs of impaired organ
perfusion’’ for individual patients in response to fluid administra-
tion. Closed lines low MFI group (MFI \2.6 at baseline), dotted
lines high MFI group (MFI C2.6 at baseline). *p \ 0.001
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underline the importance of selecting patients eligible for
fluid therapy and monitoring the effects. Since none of the
macrohemodynamic variables at baseline discriminated
for MFI\2.6, it seems relevant to assess organ perfusion
at the level of the microcirculation. The fact that scoring
of MFI has been demonstrated to be feasible in real time
at the bedside adds to its clinical applicability for
selecting patients and monitoring therapeutic interven-
tions [21]. As shown in our data, it is of note to use
variables of flow (MFI or PPV) rather than variables that
represent capillary distance (PVD, TVD).
Apart from our newly suggested approach to select
patients prior to fluid therapy, our data seem to add to the
existing literature in other perspectives as well. Previous
publications linked (the persistence of) rather gross
microvascular alterations to organ dysfunction, severity of
illness, and prognosis [12, 17, 22–24]. In these studies,
with relatively small sample sizes, strict selection of
specific subgroups of patients, with profound abnormali-
ties at baseline, are helpful to detect potential
mechanisms. However, such studies do not mimic clinical
reality to the full extent. Clinical decision-making in the
ICU is often characterized by uncertainties regarding
whether to intervene in relatively mild abnormalities in a
heterogeneous population. In our study, median MFI was
‘‘only’’ 2.5 and median PPV 90 %, with a lowest 25th
percentile at 2.3 and 86 %, respectively. These data add to
the understanding that even relatively mild microvascular
flow alterations are associated with clinical signs of
impaired organ perfusion, and may be mitigated by
therapy, before transition to prolonged organ dysfunction
[20, 25]. Furthermore, our data seem to expand the
existing knowledge of microvascular abnormalities and
response to fluid therapy, from predominantly sepsis
patients [9, 10] to a more heterogeneous ICU population.
The relationship between the commonly used concept
of ‘‘fluid responsiveness’’ (i.e., DSVi C10 % in response
to a fluid challenge) and the mitigation of microcircula-
tory abnormalities seems to be rather complex. At
baseline, the static dichotomous variable responder/non-
responder discriminated neither between MFI \2.6 or
C2.6 nor between the presence or absence of ‘‘clinical
signs of impaired organ perfusion.’’ This highlights the
issue that a significant increase in SV after fluid admin-
istration is not equal to the need for fluid therapy. In daily
practice not only is ‘‘fluid responsiveness’’ difficult to
predict [26], but means (‘‘responsiveness’’) and objective
(improvement of organ perfusion) are also often mis-
taken. Moreover, the absolute increase in MFI was equal
in patients with and without an increase in SVi C10 %.
Our observations suggest that, within the 30-min time
window of the fluid challenge, microcirculatory flow
alterations may improve, independent from the change in
SV. This seems to be in contradiction to the idea that a
systemic enhancement of flow (e.g., cardiac output) is a
prerequisite for an augmentation of organ perfusion at the
level of the microcirculation.
These data seem to be in line with the existing liter-
ature. In preload-dependent septic patients, with marked
microvascular alterations at baseline, the effect of fluid
therapy was reflected both at the level of the heart and in
the microcirculation [9]. However, in this study nonre-
sponders and nonseptic patients were not included. Others
observed a time-dependent relation between fluid
administration and microvascular response in septic
patients, irrespective of (a change in) blood pressure or
cardiac output [10]. This might be due to differences in
the pathophysiology of microvascular alterations over
time. However, the fact that, in this study, microvascular
variables were considerable higher in the late phase of
sepsis than in the early phase also underpins the impor-
tance of establishing the magnitude of potentially
correctable abnormalities prior to intervention.
Several limitations of the study need to be addressed.
Firstly, this was an uncontrolled study. Although the
observation period was short (30 min), spontaneous
improvement in microvascular blood flow cannot be ruled
out. However, as of now, denial of fluids is considered
unethical under these circumstances. Secondly, the
absence of effect on clinical signs of organ perfusion may
have been hampered by the chosen timeframe and
amount/type of fluid administered. Clinical signs may
have needed longer time to respond to the intervention,
and in individual patients more fluids may have been
necessary to detect effects. The fact that both crystalloid
and colloid solutions have been used is of potential con-
cern. Some authors observed marked differences in
microvascular response after 24 h in sepsis with either
isotonic saline or HES 6 % 130/0.4 [27], whereas others
could not observe such difference between Ringer’s lac-
tate and 4 % albumin [10], or colloids and hypertonic
saline [7, 28]. In a post hoc analysis we were unable to
demonstrate significant differences in SV and MFI in
response to different types of fluids (Electronic Supple-
mentary Material). Thirdly, the definitions of impaired
organ perfusion were chosen in line with a local protocol,
rather than a more standardized SOFA score. Although
small but significant changes in SOFA score have been
described to be associated with microvascular alterations
during protocol-directed resuscitation [25], we considered
large parts of the SOFA score potentially insensitive to
detect changes in organ perfusion. Lastly, we used the
tongue as a window to observe the microcirculation. It is
conceivable that other organs may express different
microvascular abnormalities at baseline [18, 29], or in
response to fluid administration [30].
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Conclusions
In the present study microvascular flow abnormalities,
defined as MFI \2.6, were present in two-thirds of
hemodynamically unstable ICU patients with ‘‘clinical
signs of impaired organ perfusion.’’ In response to fluid
administration, a significant increase in microvascular
blood flow and attenuation of ‘‘clinical signs of impaired
organ perfusion’’ were restricted to patients with MFI
\2.6 at baseline. This response was irrespective of a
change in SV. These data add to the understanding that
noninvasive assessment of microvascular perfusion may
help to identify patients with potential need for fluid
therapy, and to evaluate its effect.
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